Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient‐derived xenograft models

Despite many efforts to understand the molecular mechanisms of pancreatic ductal adenocarcinoma (PDAC) treatment resistance, there is still no reliable method for selecting patients who could benefit from standard pharmacological treatment. Here, four PDAC patient‐derived xenografts (PDAC‐PDXs) with...

Full description

Bibliographic Details

Published in:	Molecular Oncology
Main Authors:	Alessia Anastasia, Laura Formenti, Paola Ostano, Lucia Minoli, Andrea Resovi, Lavinia Morosi, Claudia Fioravanti, Edoardo Micotti, Cristina Matteo, Eugenio Scanziani, Giovanna Chiorino, Raffaella Giavazzi, Carmen Ghilardi, Dorina Belotti
Format:	Article
Language:	English
Published:	Wiley 2025-04-01
Subjects:	pancreatic cancer patient‐derived xenografts stroma signature treatment response
Online Access:	https://doi.org/10.1002/1878-0261.13816